Overview

Intravenous Immunoglobulin After Relapse in Vasculitis

Status:
Terminated
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to study the efficacy of intravenous immunoglobulins for inducing remission in patients relapsing of systemic vasculitides.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Antibodies
gamma-Globulins
Immunoglobulin G
Immunoglobulins
Immunoglobulins, Intravenous
Immunosuppressive Agents
Rho(D) Immune Globulin